Security record · archived quarter
HAE
Haemonetics Corporation · Healthcare · Medical - Devices
16Tracked holders
—Δ holders
7.65MShares held
$633.10MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 106 | -6 | 39.46M | $2.63B | +3 | −9 |
| Q1 2026 | 115 | +1 | 38.93M | $1.98B | +9 | −9 |
| Q4 2025 | 115 | -1 | 49.79M | $3.32B | +2 | −2 |
| Q3 2025 | 19 | 0 | 21.92M | $1.07B | +1 | −2 |
| Q2 2025 | 17 | +1 | 20.74M | $1.55B | +1 | — |
| Q1 2025 | 13 | -1 | 9.03M | $573.92M | +1 | −2 |
| Q4 2024 | 14 | 0 | 9.30M | $726.05M | +1 | −1 |
| Q3 2024 | 13 | -3 | 7.86M | $631.67M | — | −3 |
| Q2 2024 | 16 | — | 7.65M | $633.10M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 3.84M | — | $317.51M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 3.84M | — | $317.51M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 3.84M | — | $317.51M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 3.84M | — | $317.51M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 1.17M | — | $97.01M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 1.17M | — | $97.01M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Fisher Asset Management ✦ | 693.05K | — | $57.34M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Norges Bank ✦ (passive) | 484.71K | — | $40.10M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 348.06K | — | $28.80M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 348.06K | — | $28.80M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 219.02K | — | $18.12M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 201.52K | — | $16.67M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 201.52K | — | $16.67M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 201.52K | — | $16.67M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 140.26K | — | $11.60M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Arrowstreet Capital ✦ | 110.11K | — | $9.11M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 109.70K | — | $9.08M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 102.79K | — | $8.50M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 83.99K | — | $6.95M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 83.99K | — | $6.95M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 83.99K | — | $6.95M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 55.50K | — | $4.59M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Marshall Wace ✦ | 44.89K | — | $3.71M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Marshall Wace ✦ | 44.89K | — | $3.71M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Bridgewater Associates ✦ | 43.57K | — | $3.60M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 4.92K | — | $406,866 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 321 holders, 47.04M shares, $2.56B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API